Home Trials A Prospective, Multicenter, Randomized, Controlled Clinical Trial to Evaluate the Safety and Effectiveness of the Hydrus Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery Email Like Tweet Plus 1 Pin It Trial ID: IRB-13-6282 Quang Nguyen The objective of this study is to demonstrate the ability of the Hydrus Implant to lower intraocular pressure in glaucoma patients undergoing cataract surgery. Inclusion Criteria: Diagnosis of Primary Open Angle Glaucoma or Pseudoexfoliative Glaucoma. Operable, age-related cataract eligible for phacoemulsification. Exclusion Criteria: Closed Angle and narrow angle forms of Glaucoma. Other Secondary Glaucoma, (such as neovascular, uveitic, traumatic, steroid induced, lens induced); glaucoma associated with increase episcleral venous pressure; congenital or developmental glaucoma.